Kevin M Brown

Title: Kevin M Brown: Innovator in Toxoplasma Detection

Introduction

Kevin M Brown is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of immunology, particularly in the detection of toxoplasma infections. With a total of 3 patents, his work has implications for both medical diagnostics and public health.

Latest Patents

One of Kevin's latest patents focuses on antigens for detecting toxoplasma infection by monitoring cellular immunity. These antigens provide a specific and strong delayed type hypersensitivity (DTH) immune response, or stimulate IFN-γ secretion, which is crucial for testing subjects for infection. Various skin testing formats can be adapted for this purpose, including patches, needles, or prongs. The presence of DTH indicates an infection, and alternate methods of detecting a T cell response, including monitoring IFN-γ secretion, may also be utilized.

Career Highlights

Throughout his career, Kevin has worked with prestigious organizations such as Washington University and Mastercard International Incorporated. His experience in these institutions has allowed him to develop and refine his innovative ideas in the field of immunology.

Collaborations

Kevin has collaborated with esteemed colleagues, including Laurence David Sibley and Qiuling Wang. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Kevin M Brown is a distinguished inventor whose work in detecting toxoplasma infections has the potential to enhance diagnostic methods in healthcare. His contributions to immunology reflect a commitment to innovation and public health.